Showing results (21-30 of 886) with videos related to

Sort By:
Pageof 89
European Journal of Cancer & Clinical Oncology|April 1, 1988
Combination therapy with flutamide and [D-Trp6]LHRH ethylamide for stage C prostatic carcinomaA Dupont, F Labrie, M Giguere, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1993
Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigenF Labrie, A Dupont, R Suburu, et al.
Archives of Sexual Behavior|February 1, 1988
Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castrationL Rousseau, A Dupont, F Labrie, et al.
The Journal of Urology|October 1, 1987
Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonistF Labrie, A Dupont, A Belanger, et al.
The British Journal of Ophthalmology|June 1, 1986
Ocular toxicity of Anandron in patients treated for prostatic cancerC Harnois, M Malenfant, A Dupont, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1978
Enzymatic degradation of somatostatin by rat plasma and hypothalamusA Dupont, G Alvarado-Urbina, J Côté, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogenR St Arnaud, R Lachance, A Dupont, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 1, 1986
Stimulation of the circulating levels of glycoprotein hormone alpha-subunit after combined administration of a luteinizing hormone-releasing hormone (LHRH) agonist and flutamide in patients with cancer of the prostateR St-Arnaud, R Lachance, A Dupont, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 89